How Viagra Became A $3-Billion-Dollar-a-Year Industry

The very first Viagra print ad. It appeared in Esquire in August 1998. Esquire

Esquire: How Viagra Went from a Medical Mistake to a $3-Billion-Dollar-a-Year Industry

Two unlikely dudes took on Wall Street, pharma nerds, and God—and got America hooked on a little blue pill.

According to the Chinese calendar, 2017 was the Year of the Cock. 2018 is the Year of the Dog. And, in Dog years, this is also the Year of the Cock Pill: Viagra.

The revolutionary erectile-dysfunction drug is celebrating the twentieth anniversary of its Brobdingnagian launch in a most auspicious way: by finally going generic.

The ramifications for generic sildenafil (the scientific name) are huge for your pocketbook and your health. Viagra’s high demand and cost (about seventy dollars a pill) have made it among the most bootlegged meds in the world, and one of the top sellers for Internet pharmacies. A study presented at the World Meeting on Sexual Medicine found that 77 percent of Viagra sold online was fake. Counterfeit Viagra and similar impostors have been linked to liver damage, strokes, and death. Just a few years back, former Los Angeles Lakers star Lamar Odom ended up face-planted in a Nevada brothel from coke and phony herbal fucklements. “He was taking herbal Viagra,” brothel owner Dennis Hof said at the time, “and a lot of it.” The availability of generic sildenafil cuts the price of the pills in half and promises greater assurance that the pill you pop won’t be your last.

Read more ....

WNU Editor: The need for the blue pill was (and still is) there.

The Beginning Of Bioelectronics

Healthcare: Into The Cortex -- Financial Times

Scientific advances on the brain promise to transform the pharmaceutical industry.

Imagine a pharmaceutical company 20 or 30 years from now. Moving beyond conventional drugs that interact biochemically with the body, it will have built a big “bioelectronics” business that treats disease through electrical signalling in the brain and elsewhere.

Neurological problems, from stroke and epilepsy to depression, will be treated through electronic implants into the brain rather than pills or injections. Even diabetes and obesity will be attacked in ways that seem like science fiction today, by sending electrical signals to malfunctioning cells.

Read more ....

My Comment: An implant inside my brain .... not a comforting thought.

The Age Of Enhancement

From Prospect:

A cornucopia of drugs will soon be on sale to improve everything from our memories to our trust in others.

On 6th December 2004 a baby girl named Yan was born. Her father, an internet entrepreneur, is called Shen Tong. Yan was Shen’s first child, and you might have expected him to have an excitable, sleepless night. But oddly the opposite occurred. He slept better than he had done for 15 years, six months and two days. It’s possible to be exact about the timing because 15 years, six months and two days earlier was 4th June 1989 and on that day Shen had been on a boulevard just off Tiananmen Square in Beijing. He was a 20-year-old student, and like thousands of others he was demonstrating in favour of political reform.

Read more ....

Chemical Neurowarfare

From Ryan Sager - Neuroworld:

Imagine a future where the Iranian regime didn’t need to spend weeks in the streets beating, killing, and jailing protesters to put down the reform movement. Imagine in this future that the beatings would be replaced with something gentler, but ultimately more sinister: non-lethal, weaponized drugs designed to decrease aggression and increase trust.

That’s the future imagined and fretted over in an opinion piece (non-gated, samizdat version here) and editorial (PDF) in the current issue of Nature.

Read more ....

My Comment: Chemical weapons .... but with a twist. This is a fascinating article, and probably more real than we think.

This reminds me of an article that was published in The Telegraph last year titled .... Future wars 'to be fought with mind drugs'.

New Drug Approvals By The FDA At An All Time Low (Opinion)

Sick Patients Need Cutting-Edge Drugs
By Gregory Conko -- Wall Street Journal

Anna Tomalis was a bright, pretty, 13-year-old girl who liked horseback riding and soccer. During the last few years, she rarely had a chance to think about those things. Since September 2005, Anna battled cancer. And, instead of wringing all she could out of childhood, this courageous teenager tried to get members of Congress to act like adults.

Anna had embryonal sarcoma, a rare form of liver cancer. Surgery and chemotherapy seemed to work at first, but the tumors came back. In March of this year, doctors told her there was nothing more they could do.

Read more ....